Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.
about
The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewImpact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantationIntestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease.Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHDAntigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation.Skin graft rejection by beta 2-microglobulin-deficient mice.Mechanism of the rejection of major histocompatibility complex class I-disparate murine skin grafts: rejection can be mediated by CD4+ cells activated by allo-class I + II antigen in CD8+ cell-depleted hosts.Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibersCellular basis of the proliferative response of human T cells to mouse xenoantigensSpecific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cellsInduction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.Effector cells in allelic H-2 class I-incompatible skin graft rejectionEvidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinantsTolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells.Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivoContribution of direct and indirect recognition pathways to T cell alloreactivity.Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activityMEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner.Allogeneic Th1 cells home to host bone marrow and spleen and mediate IFNγ-dependent aplasia.Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).The scid mouse: mutation in a DNA repair gene creates recipients useful for studies on stem cells, lymphocyte development and graft-versus-host disease.Mouse models of bone marrow transplantationPerforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantationIn vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T-cell help.Antigen-presenting cells for CD8+ T cells.Mouse models of graft-versus-host disease: advances and limitationsThe role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics.Acute lethal graft-versus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones.Murine models of transplantation tolerance through mixed chimerism: advances and roadblocks.Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo.Recognition requirements for the activation, differentiation and function of T-helper cells specific for class I MHC alloantigens.Current thoughts on the pathogenesis of graft versus host disease.Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells.Indirect T cell recognition in allograft rejection.Recent advances in graft-versus-host disease (GVHD) prevention.Strong T cell tolerance in parent----F1 bone marrow chimeras prepared with supralethal irradiation. Evidence for clonal deletion and anergy.
P2860
Q28066083-CF8A8E93-0448-45D6-8896-8196B295FB5DQ33898020-B19C4DBC-BE30-4152-BE82-7FA8E2B2F3ACQ34581469-144812CE-586C-489C-A604-FE3B00A0BB80Q34788330-004AF4AE-60A1-428C-A526-990CBAEC9F62Q34974093-608307F0-B3FE-452E-8031-4C5721AE927EQ36229698-72BA69D4-2253-45CE-B100-9466C477D79BQ36231155-CC27A195-0642-4AF7-89B0-66E72B1D29B1Q36231684-23893A18-60AF-4DFA-8D65-62D35B1F11C1Q36234961-02FF4F5F-E0D0-4F08-8127-45B801830B47Q36350220-6E487A2B-D929-4065-B54D-84B42B660D48Q36350238-C6311845-0AC6-42B6-8C36-A8C3A1FE0A20Q36350884-49072D19-4CFC-4AE5-B308-62A72D077188Q36352067-D906AD37-D596-49BC-94EB-55F5541793F0Q36352580-C44A4656-EF7E-4F91-B3CB-6FC45D01BF49Q36353989-0FC5D777-9161-45C1-8512-682A61AEE43EQ36355038-04C06A24-1AA9-4645-891C-E89373B03017Q36356623-E51CD129-3B68-4083-888E-00ABECB506DDQ36361067-80E8FE4D-5B07-42C8-947E-F56F25B35D3AQ36361819-A64A5B8B-346B-480A-B6C4-3C24F5F1E514Q36370863-393217E6-A181-4110-8099-36708F992B72Q36447926-D494CF81-EBB5-4399-A396-ECDC39BF90A6Q36907824-63C929E9-D56B-4EFE-9837-ABEB1BBA8FFEQ36931745-C1DF9735-BE6B-41CC-8BAD-A200264297D0Q36987833-FBDC51DC-6E0C-433C-A919-6B104C87D772Q37019302-7F10A43E-6983-4C2D-8244-EA48F5AF4090Q37045969-67671E2D-8ABC-449B-867C-C24AC31B860DQ37371294-B1E4F65A-C2CA-4295-A590-1B57698E5C1FQ37734491-9FD49684-0041-43F4-9A06-6B45D5389417Q37829524-477D1B78-FFE8-490D-B826-26D7F84352B2Q37874011-8EE43B05-641A-4461-919E-F5EE587E491DQ37989141-3AEA8DF4-EF6D-483E-80D3-EB7AF1C1C53AQ38534445-AF560A8A-1D7B-4FDD-82DE-2116FA5F2371Q39232140-A09E11F6-2E8A-488C-B421-61250513E9A8Q39479246-240BB90D-0081-418F-8F84-12B9A96CA237Q39482936-6F4A3AA1-9FB2-44FB-AFED-2B90E83F7E50Q39619946-02745342-A6A3-44EC-8CAF-CE57AFA9DF81Q40163989-74DE1214-8B7F-49CC-BAC3-C2804AC7AD60Q41091920-805A5A2B-539F-4C82-9501-2B3393760F7EQ41561701-F1EE4748-5BFE-4D23-910A-6B037CEE76A3Q41808135-7E749A99-6EB7-4DF6-A649-B95581464410
P2860
Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Properties of purified T cell ...... vs. class II H-2 differences.
@en
Properties of purified T cell ...... vs. class II H-2 differences.
@nl
type
label
Properties of purified T cell ...... vs. class II H-2 differences.
@en
Properties of purified T cell ...... vs. class II H-2 differences.
@nl
prefLabel
Properties of purified T cell ...... vs. class II H-2 differences.
@en
Properties of purified T cell ...... vs. class II H-2 differences.
@nl
P2093
P2860
P356
P1476
Properties of purified T cell ...... vs. class II H-2 differences.
@en
P2093
P2860
P304
P356
10.1084/JEM.163.4.998
P407
P577
1986-04-01T00:00:00Z